Artwork for podcast Pathfinders in Biopharma
Pharma Understands Phase One Data – But Does the Market?
Episode 27 • 21st June 2024 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:25:30

Share Episode

Shownotes

Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.

Follow

Links

Chapters

Video

More from YouTube